A secure supply chain and integrity of drug packaging are important aspects for pharmaceutical manufacturers. Regulations such as the EU Falsified Medicines Directive contribute to supply chain security but address only secondary packaging. By contrast, primary containers like prefilled syringes require more specific solutions for tamper evidence and first-opening indication. Due to its integrated plastic trap, the Needle-Trap needle protection label poses special challenges to a first-opening indication feature.